Newtown, PA January 4, 2016: Founder Dr. Colin Miller today announced that company, EveryClinicalTrial (www.everyclinicaltrial.com) was “open for business” and already has contracts in place and providing services for clients. The requirements for registering and publishing trial results on ClinicalTrial.gov is both difficult and time consuming, so EveryClinicalTrial (ECT) provides the “go to” cost effective solution to those conducting clinical trials. While there are currently 200,000 trials registered on ClinicalTrial.gov, less than 20,000 have reported results. The current recommendations are to post results within 12 months of completing a trial and there is new legislation pending in congress which may tighten up the requirements. Colin Miller, ECT’s CEO states: “We believe that incomplete, inaccurate, misleading, or delayed reporting of medical research may result in poorly informed decision making and reduce the efficiency and quality of health care. Therefore, scientific and clinical research should be reported in a complete, accurate, balanced, and timely manner and we aim to help support this goal.”
• • To aid researchers in these new requirements, ECT offers two primary services: Protocol+ for the registration of trials and Results Services for the publications of trial results. Bill Blank, VP of Sales and Marketing comments: “typically a client does not work regularly with these requirements and it can be quite frustrating, not to mention the costly risk of non-compliance with reporting standards. Our experience and tools allow us to dramatically reduce the time to format and register their information, enabling us to offer an effective and low-cost solution for this challenge.”
• • ECT will be based in Newtown, PA and has plans to add 10+ employees over the next 12 months. The company is currently well funded by a group of private investors.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.